News
Laird Superfood, a company founded by the surfer Laird Hamilton, is riding the IPO wave and filed for a $40 million fundraise from investors to appear on the New York Stock Exchange. The company indicated it will use the symbol “LSF.”
The five-year-old company said it is looking to “build the first scale-level and widely recognized brand that authentically focuses on natural ingredients, nutritional density and functionality.” Laird Superfoods sells a variety of superfood products including mushroom coffee, Peruvian coffee beans, coconut sugar and superfood coffee creamers with MCTs.

While the company is small, it is playing in a big category. In its filing, the Laird estimated the market for the natural, organic and functional foods and beverages at $152 billion. This category, although already large, has grown as a result of the pandemic where consumers are looking for better-for-you products to supplement their health and wellness. A Beneo survey from May showed that globally, 75% of consumers said they planned to eat or drink more healthfully as a result of the pandemic.
Although this segment is growing quickly, and Laird is growing successfully as a company – last year, the company generated net sales of $13.1 million and captured $11.1 million in the first six months of 2020 – it is curious that the company is filing for an IPO rather than pursuing an acquisition. Over the five years Laird has been in operation, it has successfully closed six funding rounds for a total of $51 million, according to Crunchbase. Its largest investor is Danone’s venture capital arm, Danone Manifesto Ventures, holds a 13.4% stake in the company. In April, Danone Manifesto Ventures invested $10 million in the company.
Regardless of the reason, going public is likely to rake in millions of dollars for the brand to continue expanding. It already retails in about 5,500 stores, but the majority (57%) of its sales come from e-commerce platforms. Coupled with the growth in the better-for-you segment, Laird will have plenty of runway to continue to grow. In particular, the company noted that repeat business from products that cater to daily rituals like coffee and creamer have solidified the foundation on which the company will focus on building business.
No pricing terms for the stock offering were announced in the filing.
23 Dec 2025
From trade tariffs to heavy metals in protein, we look back at some of the industry’s highlights of 2025 and round up our most-read stories of the year.
Read more
19 Dec 2025
Non-profit organisation the Food Foundation has launched a campaign, “Bang in Some Beans”, designed to increase UK consumers’ legume consumption.
Read more
12 Dec 2025
Europe’s $40.7 billion supplements market is growing fast, fuelled by demand for products that support healthy ageing, mental wellbeing, and preventive health, say experts.
Read more
11 Dec 2025
Whole Foods Market has released its top 2026 trends, predicting that a fibre frenzy will take place next year as health-conscious consumers seek out nutritious, filling options.
Read more
9 Dec 2025
With the launch of Novak Djokovic’s sorghum-based brand, the grain’s popularity in the better-for-you snacking sphere is on the rise, thanks to its nutritional and sensory properties.
Read more
8 Dec 2025
Plant-based dairy is a maturing market that still faces significant hurdles around taste, functionality, nutrition, and price, but industry is innovating fast, according to experts speaking at Fi Europe.
Read more
3 Dec 2025
Food industry stakeholders celebrated as the winners of the Fi Europe Innovation Awards were announced at a ceremony in Paris.
Read more
28 Nov 2025
Entries for the Vitafoods Europe Innovation Awards 2026 are now open! Game-changing companies have until 27 February to submit their entry across eight categories for the chance to win big.
Read more
25 Nov 2025
Cinnamon may be a top functional ingredient, but it needs stronger protocols to ensure it meets EU food safety laws and quality standards, say researchers.
Read more
24 Nov 2025
OXO’s entry into bone broth has turned the spotlight on this small but high-performance category – and there is still scope for growth, especially in the area of GLP-1 support.
Read more